Nutrien Ltd.

NTR
Delayed Toronto Stock Exchange - 04/08 10:00:00 pm
50.23CAD
+2.76%
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2019 2020 (e)
Sales 19 255 19 597
EBITDA 4 025 3 926
Operating profit (EBIT) 1 862 2 053
Pre-Tax Profit (EBT) 1 308 1 584
Net income 992 1 160
P/E ratio 28,1x 17,3x
EPS ( $ ) 1,70 2,08
Dividend per Share ( $ ) - 1,80
Yield - 5,01%
Reference price ( $ ) 47,827 35,859
Announcement Date 02/18/2020
10:24pm
-
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2019 2020 (e)
Debt - 9 828
Finance 0,00 -
Operating income (EBITDA) 4 025 3 926
Leverage
(Debt/EBITDA)
- 2,50x
Capital Expenditure - 1 281
Free Cash Flow (FCF) - 1 827
Book Value Per Share (BVPS) ( $ ) - 39,8
Cash Flow per Share ( $ ) - 5,11
Announcement Date -
Balance Sheet Analysis
Financial Ratios
Size 2020e 2021e
Capitalization 20 409 M $ -
Entreprise Value (EV) 30 237 M $ 30 113 M $
Valuation 2020e 2021e
P/E ratio (Price / EPS) 17,3x 13,6x
Capitalization / Revenue 1,04x 0,99x
EV / Revenue 1,54x 1,46x
EV / EBITDA 7,70x 7,01x
Yield (DPS / Price) 5,01% 5,18%
Price to book (Price / BVPS) 0,90x 0,89x
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) 10,5% 11,6%
Operating Leverage (Delta EBIT / Delta Sales) 5,78x 3,03x
Net Margin (Net Profit / Revenue) 5,92% 7,26%
ROA (Net Profit / Asset) 2,64% 3,08%
ROE (Net Profit / Equities) 4,84% 5,91%
Rate of Dividend 86,5% 70,7%
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   6,54% 6,32%
Cash Flow / Sales 14,8% 14,4%
Capital Intensity (Assets / Sales) 2,24x 2,35x
Financial Leverage (Net Debt / EBITDA) 2,50x 2,25x
Price Earning Ratio
BNA & Dividende